- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01043835
Comparison of Laparoscopic Versus Open Gastrectomy for Advanced Gastric Cancer:A Prospective Randomized Trial
Prospective Randomized Trial of Laparoscopic Versus Open Gastrectomy for Advanced Gastric Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: The use of laparoscopic surgery in the management of advanced gastric cancer (AGC) has not yet met with widespread acceptance and remains limited to only a few centers.
Intervention: According to tumor pathological stage (JGCA, 2nd English ed), location of tumor, and patient clinical condition, a laparoscopy-assisted radical gastrectomy and open gastrectomy were performed. Laparoscopy-assisted radical gastrectomy consisted of the following procedures: 1) laparoscopic dissection of the lesser and greater omentum, ligation and division of the main vessels to mobilize the stomach under pneumoperitoneum, 2) laparoscopic D2 lymph node dissection, based on the Guidelines of the Japan Gastric Cancer Association and 3) resection of the distal two thirds (LADG), proximal third (LAPG), or total stomach (LATG), depending on the location of the tumor, followed by reconstruction by the Billroth I, Billroth Ⅱ, esophagogastrostomy, or Roux-en-Y method through a 3 to 5-cm-long minilaparotomy incision.
Follow-up schedule: All patients were monitored postoperatively by physical examination, and blood tests including a test for serum carcinoembryonic antigen (CEA) at least every three months for the first year, every six months for the next two years, and every year for the fourth and fifth year, and thereafter by abdominal ultrasonography, CT, chest radiography, and gastroscopy at least once each year.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Chong Qing
-
Chong Qing, Chong Qing, China, 400038
- Department of General Surgery and Center of Microinvasive Gastrointestinal Surgery, Southwest Hospital
-
Chong Qing, Chong Qing, China, 400038
- Southwest Hospital, China
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pathologically proven gastric adenocarcinoma
- Age:older than 18 years old,younger than 80 years old
- Preoperative stage(CT, GFS stage):cT2N0M0, cT2N1M0, cT2N2M0, cT3N0M0, cT3N1M0,cT3N2M0
- ASA score:≤3
- Patients with an invasion of the gastric serosa exceeding 10 cm2 according to ultrasound examination or examination during surgery were excluded
- No history of other cancer
- No history of chemotherapy or radiotherapy
- Written informed consent
Exclusion Criteria:
- Concurrent cancer patients or patient who was treated due to other types of cancer before the patient was diagnosed as a gastric cancer patient
- Patient who was treated by other types of treatment methods, such as chemotherapy, immunotherapy, or radiotherapy
- Patient who was received upper abdominal surgery (except, laparoscopic cholecystectomy)
- ASA score:>3
- Contraindication of laparoscopy: severe cardiac disease, abdominal wall hernias, diaphragmatic hernias, uncorrected coagulopathies, portal hypertension, pregnancy
- Complicated case needed to get emergency operation
- Any accompanying surgical condition needed to be performed in same time
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Laparoscopy-assisted gastrectomy
|
A 10-mm trocar for laparoscope was inserted below the umbilicus.
Another 10-mm trocar was introduced in the left preaxillary line 2 cm below the costal margin as a major hand port,and a 5-mm trocar was placed at the contralateral site for traction.
A 5-mm trocar was inserted in the left midclavicular line 2 cm above the umbilicus as an accessory port, and a 15-mm trocar also as an accessory port was placed at the contralateral site.
The operator stood on the left side of the patient.
Subtotal or total gastrectomy and D2 lymph node dissection will be performed basically.
As a general rule, Billroth I, Billroth II or Roux-Y method was used for gastric reconstruction.
Dissected stomach and lymph node are collected through additional 5 cm incision at a median superior abdominal incision.
|
Active Comparator: Open gastrectomy
|
Approximately 15~20 cm length incision is made from falciform process to periumbilical area.
Subtotal or total gastrectomy and D2 lymph node dissection will be performed basically.
As a general rule, Billroth I, Billroth II or Roux-Y method was used for gastric reconstruction for all cases.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Disease free survival
Time Frame: 3 years
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Complications, recurrence, quality of life measured by EORTC QLQ-C30 V 3.0 and EORTC QLQ-STO22
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 197691197392
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrectomy
-
Methodist Health SystemIntuitive SurgicalRecruitingLaparoscopic Sleeve Gastrectomy | Sleeve GastrectomyUnited States
-
Samsung Medical CenterSamsung ElectronicsCompleted
-
Solvay PharmaceuticalsCompletedGastrectomyDenmark, Finland, Norway, Sweden
-
Anhui Medical UniversityUnknown
-
Miguel BurchCedars-Sinai Medical CenterTerminated
-
University of MiamiEnrolling by invitation
-
Beijing Friendship HospitalPeking Union Medical College Hospital; Beijing Tiantan Hospital; Beijing Hospital and other collaboratorsCompleted
-
Fatih Sultan Mehmet Training and Research HospitalCompletedLaparoscopic Sleeve Gastrectomy
-
The Catholic University of KoreaWithdrawnPost Gastrectomy State
-
Universiti Putra MalaysiaUnknownLaparoscopic Sleeve Gastrectomy
Clinical Trials on Laparoscopy-assisted gastrectomy
-
Seoul National University Bundang HospitalTerminatedGastric CancerKorea, Republic of
-
National Cancer Center, KoreaUnknownGastric CancerKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruiting
-
Fujian Medical UniversityEnrolling by invitation
-
Fujian Medical UniversityEnrolling by invitation
-
The Catholic University of KoreaUnknownStomach NeoplasmKorea, Republic of
-
Soonchunhyang University HospitalUnknownGastric CancerKorea, Republic of
-
Fudan UniversityRecruiting
-
National Cancer Center, KoreaUnknownGastric CancerKorea, Republic of
-
National Cancer Center, KoreaCompletedEarly Gastric CancerKorea, Republic of